429 Chimeric antigen receptor T-cell therapy (CAR-T), a new type of cellular immunotherapy, has shown high efficiency and wide clinical application value in the treatment of various hematological malignancies in recent years
You may get a faint scar from this type of treatment
They propose based on rodent and monkey studies that this kind of molecule, when administered at high enough doses, may result in weight loss comparable to the weight loss seen with drugs that include GLP-1 as a target, and without the tolerability issues like nausea and vomiting that often come with the approved treatments, according to a peer-reviewed draft paper published this week
For researchers who have desensitized to dual agonist therapy, the addition of the glucagon receptor pathway provides genuinely novel stimulation
They argued that, as the Noom spokeswoman put it, a number of studies have demonstrated sustained weight loss post medication removal. The research they sent, however, underscores how nascent this particular area still is
